ARTICLE | Clinical News
RheothRx: Began a multinational Phase III trial
May 9, 1994 7:00 AM UTC
CytRx Corp. (CYTR), Norcross, Ga. Product: RheothRx, a tripolymer that coats blood cells, making them slippery and more able to slide past clots Indication: Limit heart damage in heart attacks Status:...